Intelligence for decisions, partnerships and market expansion.
Economic reporting from around the world, filtered to the sectors and policy areas our members build in — part of the same intelligence stream behind the Global Economic Outlook and NiDCC's market reports.
Raymond James has reiterated a Strong Buy rating and a $50.00 price target for Tyra Biosciences (NASDAQ: TYRA) following a discussion with the company's CEO. The firm highlighted t...
Quantum BioPharma has signed a contract with Thermo Fisher Scientific’s clinical research business to begin the Phase 2 clinical trial for Lucid-MS, a novel neuroprotective therapy...
Investors are re-evaluating Charles River Laboratories International (NYSE:CRL) due to a record-setting Nasdaq and high bond yields, prompting a reassessment of clinical demand and...
Iqvia Holdings (NYSE:IQV) is gaining market attention due to the record-setting Nasdaq and high bond yields, prompting investors to re-evaluate clinical demand and healthcare deliv...
Quantum BioPharma Ltd. (NASDAQ: QNTM) is partnering with Thermo Fisher Scientific Inc.'s (NYSE: TMO) clinical research division to launch a Phase 2 clinical trial for its progressi...
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher Scientific's clinical research business to begin its Phase 2 Lucid-MS trial for multiple sclerosis. This...
Thermo Fisher Scientific is expanding its drug development, manufacturing, and clinical capabilities, which will be showcased at CPHI Milan 2026. Key advancements include new OSD E...
RBC Capital has increased its price target for Danaher from USD 215.00 to USD 250.00, maintaining an Outperform rating. This adjustment reflects multiple expansion among peers and...
This article is a brief notification from Investing.com about a Form 4 filing for Cencora Inc on October 6. It provides a direct link to view the filing and includes general market...
60 Degrees Pharmaceuticals Inc. (NASDAQ: SXTP) shares initially fell by 6.22% in pre-market trading ahead of interim results from a clinical trial of tafenoquine for severe babesio...